Chengdu Easton Biopharmaceuticals Co Ltd (688513) — Cash Flow Reinvestment Rate
Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a Cash Flow Reinvestment Rate of 0.40x as of September 2025, reinvesting CN¥24.30 Million (capex CN¥24.30 Million ) from operating cash flow of CN¥61.35 Million. Check 688513 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Chengdu Easton Biopharmaceuticals Co Ltd Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Chengdu Easton Biopharmaceuticals Co Ltd across 13 annual periods. Explore Chengdu Easton Biopharmaceuticals Co Ltd (688513) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Chengdu Easton Biopharmaceuticals Co Ltd (2013–2025)
Year-by-year capital reinvestment analysis for Chengdu Easton Biopharmaceuticals Co Ltd. For live market cap and broader valuation context, see 688513 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.40x | CN¥105.96 Million | CN¥264.94 Million | CN¥86.28 Million | ▼ -11.5% |
| 2024 | 0.45x | CN¥118.92 Million | CN¥263.24 Million | CN¥117.42 Million | ▼ -78.8% |
| 2023 | 2.13x | CN¥585.44 Million | CN¥275.25 Million | CN¥175.26 Million | ▼ -56.6% |
| 2022 | 4.90x | CN¥745.03 Million | CN¥151.94 Million | CN¥339.33 Million | ▲ +97.3% |
| 2021 | 2.49x | CN¥366.88 Million | CN¥147.60 Million | CN¥256.29 Million | ▼ -59.3% |
| 2020 | 6.10x | CN¥955.44 Million | CN¥156.52 Million | CN¥198.81 Million | ▲ +372.0% |
| 2019 | 1.29x | CN¥183.40 Million | CN¥141.83 Million | CN¥95.41 Million | ▲ +181.4% |
| 2018 | 0.46x | CN¥76.63 Million | CN¥166.79 Million | CN¥76.63 Million | ▲ +71.0% |
| 2017 | 0.27x | CN¥23.02 Million | CN¥85.70 Million | CN¥23.02 Million | ▲ +59.8% |
| 2016 | 0.17x | CN¥17.83 Million | CN¥106.06 Million | CN¥17.83 Million | ▼ -76.0% |
| 2015 | 0.70x | CN¥35.43 Million | CN¥50.57 Million | CN¥35.43 Million | ▲ +48.5% |
| 2014 | 0.47x | CN¥22.04 Million | CN¥46.71 Million | CN¥22.04 Million | ▼ -82.6% |
| 2013 | 2.71x | CN¥76.11 Million | CN¥28.12 Million | CN¥76.11 Million | — |